Skip to the page

Data / Form D filings / Dimension Inx Corp.

Dimension Inx Corp.: Form D filings

Dimension Inx Corp., a biotechnology company in Chicago, IL, filed 3 Form D notices with the SEC between 2020 and 2023. The latest, on February 3, 2023, reports $12 million sold of a $15 million offering to 17 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3440 SOUTH DEARBORN STREET, SUITE 142S, Chicago, IL, 60616
Phone
(312) 235-3510
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1832381

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 3, 2023New notice$15,000,000$11,999,993$3,000,00717Jan 23, 2023sec.gov
Nov 29, 2021New notice$2,286,341$2,286,34118Nov 19, 2021sec.gov
Nov 18, 2020New notice$3,385,000$3,385,00022Nov 3, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Rima ChakrabartiDirector
Ramille ShahDirector
Caralynn CollensExecutive Officer, Director

Other biotechnology companies in Illinois that filed recently

Every Form D from the week of Jan 30, 2023 · All recent filings in Illinois · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Dimension Inx Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.